Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Circulation|November 6, 2022
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 WeeksMilind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
The Annals of Thoracic Surgery|October 1, 2021
Risks and Outcomes of Reoperative Cardiac Surgery in Patients With Patent Bilateral Internal Thoracic Artery GraftsFaisal G Bakaeen, Hiba Ghandour, Kirthi Ravichandren, et al.
The Annals of Thoracic Surgery|October 17, 2018
Contemporary Surgical Management of Hypertrophic Cardiomyopathy in the United StatesLawrence M Wei, Dylan P Thibault, J Scott Rankin, et al.
The New England Journal of Medicine|November 29, 2013
Unexpected abrupt increase in left ventricular assist device thrombosisRandall C Starling, Nader Moazami, Scott C Silvestry, et al.
Circulation. Genomic and Precision Medicine|March 17, 2018
Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial FibrillationJeffrey Hsu, Shamone Gore-Panter, Gregory Tchou, et al.
The Annals of Thoracic Surgery|October 23, 2021
Right Internal Thoracic Artery Patency Is Affected More by Target Choice Than Conduit ConfigurationFaisal G Bakaeen, Hiba Ghandour, Kirthi Ravichandren, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 7, 2026
Is a Patent Internal Thoracic Artery-to-Left Anterior Descending Artery Still a Risk Factor in Patients Undergoing Isolated Redo-CABG?Rami Alaraj, Mahmoud Alshneikat, Ahmed K Awad, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 19, 2016
Long-term survival, valve durability, and reoperation for 4 aortic root procedures combined with ascending aorta replacementLars G Svensson, Saila T Pillai, Jeevanantham Rajeswaran, et al.
Heart Rhythm|March 28, 2015
Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathyMohamed Bassiouny, Bruce D Lindsay, Harry Lever, et al.
Circulation. Cardiovascular Imaging|November 6, 2022
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
Pageof 19